Renaissance Technologies - PYXIS ONCOLOGY INC ownership

PYXIS ONCOLOGY INC's ticker is and the CUSIP is 747324101. A total of 40 filers reported holding PYXIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$430
-33.6%
216,251
-14.6%
0.00%0.0%
Q2 2023$648
+71.4%
253,229
+168.8%
0.00%0.0%
Q1 2023$378
+237.5%
94,200
+12.7%
0.00%
Q4 2022$112
-100.0%
83,600
-35.1%
0.00%
Q3 2022$254,000
+41.9%
128,802
+70.9%
0.00%
Q2 2022$179,00075,3710.00%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Yu Fan 69,303$137,9129.78%
Decheng Capital Management III (Cayman), LLC 326,810$650,3520.22%
Harvest Investment Services, LLC 113,894$226,6490.15%
Laurion Capital Management LP 3,170,803$6,309,8980.04%
CORNERCAP INVESTMENT COUNSEL INC 74,903$149,0570.03%
SCHULHOFF & CO INC 22,000$43,7800.02%
HHLR ADVISORS, LTD. 382,606$761,3860.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 236,195$470,0280.01%
ExodusPoint Capital Management, LP 415,072$8260.01%
Bleakley Financial Group, LLC 11,234$22,3560.00%
View complete list of PYXIS ONCOLOGY INC shareholders